No Data
No Data
We're Keeping An Eye On Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Rate
QDX Announces Collaboration With Prelude Therapeutics on Novel Oncology Programs
Small-Cap Stocks Are Having a Moment. Check Out the 10 Biggest Winners.
Prelude Therapeutics (PRLD.US) once surged 28%! Reached clinical trial cooperation and supply agreement with Merck (MRK.US).
Recently, Prelude Therapeutics has reached a clinical trial cooperation and supply agreement with Merck.
Prelude, Merck Strike Clinical Trial Collaboration and Supply Pact
Express News | Prelude Therapeutics- Co, Merck Each Retain All Commercial Rights to Their Respective Compounds, Including as Monotherapy or as Combination Therapies
No Data